medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2015, Number 3

<< Back Next >>

Ann Hepatol 2015; 14 (3)

Black hairy tongue during interferon therapy for hepatitis C

Arab JP, Vargas JI, Morales C, Arrese M

Language: English
References: 12
Page: 414-415
PDF size: 73.24 Kb.


Text Extraction

A 64-year-old woman with history of chronic hepatitis related to Hepatitis C virus [(HCV), genotype 1b] infection received treatment with pegylated interferon (PEG-IFNα2a) and rivabirin noticed a black coloration of her tongue during the thirtythird week of treatment (Figure 1). She had no other relevant past medical history and was a nonsmoker. She did not refer any pain, discomfort or other symptoms in the oral cavity.


REFERENCES

  1. Thompson DF, Kessler TL. Drug-Induced Black Hairy Tongue. Pharmacotherapy 2010; 30: 585-93.

  2. Korber A, Dissemond J. Black Hairy Tongue. N Engl J Med 2006; 354: 67.

  3. Gurguta C, Kauer C, Berghloz U, Formann E, Steindl-Munda P, Ferenci P. Tongue and Skin Hyperpigmentation During PEG-Interferon-α/Ribavirin Therapy in Dark-Skinned Non- Caucasian Patients with Chronic Hepatitis C. Am J Gastroenterol 2006; 101: 197-8.

  4. Bachmeyer C, Pellen J-C. Tongue hyperpigmentation during hepatitis C treatment. Canadian Medical Association Journal 2012; 184: 1498.

  5. Vano-Galvan S, Jaen P. Black hairy tongue. Cleve Clin J Med 2008; 75: 847-8.

  6. Willems M, Munte K, Vrolijk J, Den Hollander JC, Böhm M, Kemmeren MH. Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection. Br J Dermatol 2003; 149: 390-4.

  7. Karabay O, Goksugur N, Ogutlu A. Tongue hyperpigmentation during interferon therapy. J Dermatol 2011; 38: 290-1.

  8. Mlika R, Kerkeni N, Marrak H, Fenniche S, Mokhtar I. Tongue hyperpigmentation during PEG-interferon-alfa/ribavirin therapy in a non-Caucasian patient with chronic hepatitis C: a case report and review of the literature. Int J Dermatol 2013; 52: 643-4.

  9. Farshidi D, Chiu M. Lingual hyperpigmentation from pegylated interferon and ribavirin treatment of hepatitis C. J Am Acad Dermatol 2010; 62: 164-5.

  10. Aguayo-Leiva I, Pérez B, Salguero I, Jaen P. Tongue hyperpigmentation during interferon-alpha and ribavirin therapy. Eur J Dermatol 2009; 19: 291-2.

  11. Fernández A, Vázquez S, Rodríguez-González L. Tongue hyperpigmentation resulting from peginterferon alfa-2a and ribavirin treatment in a Caucasian patient with chronic hepatitis C. J Eur Acad Dermatol Venereol 2008; 22: 1388-9.

  12. Ghosh S, Duseja A, Dhiman RK, Chawla YK. Tongue hyperpigmentation resulting from peginterferon alfa-2b and ribavirin treatment in a patient with chronic hepatitis C. Dig Dis Sci 2012; 57: 820-1.




2020     |     www.medigraphic.com